• 대한수의학회지
• /
• 제35권2호
• /
• pp.347-352
• /
• 1995

Closantel이 간질(Fasciola hepatica)에 감염된 소에 미치는 치료 효과를 알아보기 위하여 간질 및 쌍구흡충에 자연감염된 41두의 한우 암컷에 체중 kg당 closantel 5mg을 1회 경구투여하였다. 치료 후 2주째부터 일주일 간격으로 3회 실시한 분변검사에서 closantel로 치료한 군은 치료 후 2주째까지는 음성이었으나 치료 후 3주 및 4주째에는 3마리의 소의 분변에서 간질충란이 검출되어 97.7%의 음전율을 나타냈다. 치료군 41두 중 30두는 임신중이었으나 임신우로부터 또는 이들로 부터 태어난 송아지에서 아무런 부작용이나 이상증세가 관찰되지 않았다. 검사한 모든 소에서 쌍구흡충란이 검출되었으나 closantel 치료에 의하여 제거되지 않았다. 두번째 실험에서는 16두의 Holstein종 송아지에 실험적으로 300개의 간질 피낭유충을 인공감염시켰으며, 감염후 14주째에 이르러 모든 개체의 분변에서 간질 충란이 검출되었다. 이들에게 감염 후 18주에 체중 kg당 5mg의 closantel을 경구투여하였으며, 치료 후 2주째부터 1주일 간격으로 3회 실시된 충란검사에서 치료군의 모든 송아지가 100% 음전율을 나타냈다. 본 실험의 결과, 간질에 자연 또는 인공감염된 소에 체중 kg당 5mg의 closantel을 경구투여했을 경우, 97% 이상의 치료효과가 있음이 관찰되었다.

• 대한수의학회지
• /
• 제37권3호
• /
• pp.595-599
• /
• 1997

Male and female Sprague-Dawley rats 8 weeks of age were inoculated per os with 10 Fasciola hepatica metacercariae each. After the infection was verified by fecal examination, they were divided into four groups at 14 weeks post-inoculation; three groups were dosed orally at 10, 20 and 30mg/kg of closantel($Flukiver^{TM}$), a salicylanilide compound and the rest used as untreated control. Efficacy of closantel was monitored weekly by fecal examination of all infected animals starting during the second week post-treatment(PT) and continuing for three weeks. Closantel elicited 96.0, 86.9 and 87.4% efficacy in rats treated with 10mg/kg at the second, third and fourth week PT, respectively. It elicited a 100% efficacy in rats treated with 20 and 30mg/kg.

• 대한수의학회지
• /
• 제40권3호
• /
• pp.575-585
• /
• 2000

This study was performed to observe the influence of host immune response on the chemotherapy of mice experimentally infected with Fasciola hepatica. Following immunosuppression with prednisolone or immunoenhancement with Freund's complete adjuvant(FCA), mice were experimentally infected with 3 Fasciola hepatica metacercariae and treated with closantel at 1 week post infection. In the group of mice infected with metacercariae alone, 2 mice of 10 were dead at 10 weeks post infection(20% mortality), and adult flukes were recovered from the liver and the peritoneal cavity of the remaining 8 mice(100% infectivity). In the group of mice treated with prednisolone and infected with metacercariae, 8 of 10 mice died before euthanasia with a mean time of death earlier than the control group (p<0.05). In the group of immunosuppressed mice infected with metacercariae and treated with closantel 20mg/kg, 4 of 10 mice died before sacrifice. In the group of mice infected and treated with closantel 20mg/kg, mortality and infectivity was 10% and 30%, respectively. Similar results were observed in mice infected and treated with closantel 5mg/kg which resulted in 10% and 50% mortality and infectivity, respectively. These results indicated that the efficacy of closantel treatment was decreased in immunosuppressed mice, while the pathogenicity was increased. In immunoenhanced mice infected with metacercariae, on the other hand, the efficacy of chemotherapy with both 5mg/kg or 20mg/kg closantel resulted in only 10% infectivity. The results shown in this study strongly suggest that a close interaction between chemotherapy against F hepatica with closantel and the host immune system exists. Considering that fascioliasis is a zoonosis, treatment regimen against the infection to immunosuppressed patients may require a concurrent prescription of an appro-priate immuno-enhancing adjuvant.

• 대한수의사회지
• /
• 제33권6호
• /
• pp.342-344
• /
• 1997